The importance of the HK-VDAC1 interaction in cell survival and protection against apoptosis is well documented, and provides an attractive target for cancer therapy and the development of anti-cancer drugs (Galluzzi et al., 2008; Shoshan-Barmatz and Golan, 2012; Krasnov et al., 2013). Here, HK1 is linked to cancer.